Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ImmunityBio (IBRX) Return on Invested Capital (2016 - 2025)

ImmunityBio (IBRX) has disclosed Return on Invested Capital for 11 consecutive years, with 1.33% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital changed N/A to 1.33% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.33% through Dec 2025, changed N/A year-over-year, with the annual reading at 2.46% for FY2025, N/A changed from the prior year.
  • Return on Invested Capital for Q4 2025 was 1.33% at ImmunityBio, up from 0.65% in the prior quarter.
  • The five-year high for Return on Invested Capital was 1.74% in Q3 2021, with the low at 2.17% in Q1 2025.
  • Average Return on Invested Capital over 5 years is 0.96%, with a median of 1.03% recorded in 2023.
  • The sharpest move saw Return on Invested Capital plummeted -7229bps in 2021, then soared 110bps in 2025.
  • Over 5 years, Return on Invested Capital stood at 1.55% in 2021, then dropped by -29bps to 1.1% in 2022, then tumbled by -31bps to 0.76% in 2023, then surged by 117bps to 1.65% in 2024, then dropped by -19bps to 1.33% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 1.33%, 0.65%, and 1.74% for Q4 2025, Q3 2025, and Q2 2025 respectively.